跳转至内容
Merck
CN

SML4153

JPH203 hydrochloride

≥97% (HPLC)

别名:

(S)-2-Amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid dihydrochloride, JPH 203, dihydrochloride, JPH-203, dihydrochloride, KYT 0353, dihydrochloride, KYT-0353, dihydrochloride, KYT0353, dihydrochloride, Nanvuranlat, dihydrochloride, O-(5-Amino-2-phenylbenzoxazole-7-yl)methyl-3,5-dichloro-L-tyrosine dihydrochloride, O-[(5-Amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-L-tyrosine dihydrochloride, SCHEMBL17360639, dihydrochloride

登录并加购,请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C23H19Cl2N3O4 · xHCl
化学文摘社编号:
分子量:
472.32 (free base basis)
UNSPSC Code:
12352200
Assay:
≥97% (HPLC)
Form:
powder
Storage condition:
desiccated
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Segment

assay

≥97% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

Biochem/physiol Actions

JPH203 (KYT-0353; Nanvuranlat) selectively inhibits L-type amino acid transporter LAT1-dependent L-leucine uptake and growth in HT-29 (IC50/GI50 = 0.06/4.1 μM) and human LAT1-expressing S2 murine renal proximal tubule cell cultures (IC50/GI50 = 0.14/16.4 μM), but not human LAT2-expressing S2 cells (IC50 >10, GI50 >1000 μM). When administered via intravenous injection, JPH203 effectively inhibits HT-29-derived tumor growth in mice in vivo (6.3-25 mg/kg via daily i.v. from d0 to d13).

Disclaimer

Hygroscopic, Store with desiccant


象形图

Exclamation mark

警示词

Warning

危险代码

Hazard Classifications

Acute Tox. 4 Oral

存储类别

11 - Combustible Solids

怎么回事?

WGK 3

闪点 (F)

Not applicable

闪点 (°C)

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库